139 results on '"Naeije, Robert"'
Search Results
2. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
3. Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension
4. Lung Ultrasound, Echocardiography, and Fluid Challenge for the Differential Diagnosis of Pulmonary Hypertension
5. LUNG ULTRASOUND, ECHOCARDIOGRAPHY, AND FLUID LOADING FOR THE DIFFERENTIAL DIAGNOSIS OF PULMONARY HYPERTENSION
6. About Left Ventricular Filling Pressures in CTEPH
7. ARTISAN: A NOVEL STUDY OF MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PULMONARY ARTERIAL HYPERTENSION
8. Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation
9. Pulmonary artery pressure-directed therapies in pulmonary arterial hypertension?
10. Phenotypes of idiopathic pulmonary arterial hypertension
11. CPET for Long COVID-19
12. Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension
13. Prostacyclin Receptor Agonists Induce DUSP1 to Inhibit Pulmonary Artery Smooth Muscle Cell Proliferation
14. The Authors Reply
15. Sex and the Right Ventricle in Heart Failure With Preserved Ejection Fraction
16. The Role of Exercise Testing in Pulmonary Vascular Disease
17. A Fluid Challenge Test for the Diagnosis of Occult Heart Failure
18. Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension
19. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension
20. Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE
21. Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension
22. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
23. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction
24. Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension
25. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension
26. EFFECT OF ESUBERAPROST ON MORBIDITY AND MORTALITY IN WORLD HEALTH ORGANIZATION (WHO) FUNCTIONAL CLASS III AND IV (FC III/IV) PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 3 TRIAL- BERAPROST-314D ADDED TO TYVASO (BEAT)
27. Anatomy, Function, and Dysfunction of the Right Ventricle
28. The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension
29. Reply to “a pediatric perspective on the TAPSE/PASP ratio in pulmonary arterial hypertension”
30. Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis
31. Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension
32. Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension
33. Exercise-Induced Pulmonary Hypertension
34. Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension
35. The Right Heart International Network (RIGHT-NET)
36. The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension
37. The Right Heart-Pulmonary Circulation Unit
38. Fluid challenge predicts clinical worsening in pulmonary arterial hypertension
39. Stressing the Cardiopulmonary Vascular System: The Role of Echocardiography
40. The breathlessness of pulmonary hypertension
41. The Relationship of Hemodynamics and Exercise Capacity With Response to Riociguat Therapy in the Respite Study of PAH Patients With an Insufficient Response to Phosphodiesterase 5 Inhibitors
42. Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
43. Lung diffusing capacity in sub-Saharan Africans versus European Caucasians
44. Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component
45. Impact d’un effort statique sur la circulation pulmonaire
46. Pulmonary Hypertension in Heart Failure
47. Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors
48. Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension
49. Roles of inflammation and apoptosis in experimental brain death–induced right ventricular failure
50. Echocardiography Combined With Cardiopulmonary Exercise Testing for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.